FGFR1 and melanoma: Among melanoma patients treated with the anti-PD-1 drug pembrolizumab (GSE78220) 24, relatively higher FGFR1 mRNA expression was found in pre-treatment tumors from non-responding cases compared with that from responders (Figure S6A).